CinCor Pharma: Funding, Investors & Team (Oct 2026)
CinCor is a clinical-stage biopharmaceutical company with a mission to advance promising clinical candidates toward marketing approval. CinCor’s focus is on cardiovascular, metabolic and kidney diseases. CinCor’s lead program is CIN-107, a novel aldosterone synthase inhibitor.
CinCor Pharma has raised $225M across 1 funding round on record, the most recent a Post-IPO Equity of $225M announced in Aug 2022.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
CinCor Pharma Company Profile and Key Stats
Latest funding round on record: Aug 2022.
CinCor Pharma Funding Rounds
CinCor Pharma Founders and Leadership Team
No contact details are on record for this team yet.
CinCor Pharma Funding Compared to Other Biotechnology Startups
CinCor Pharma's latest round of $225M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like CinCor Pharma in Biotechnology and Cincinnati
Companies Similar to CinCor Pharma
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
CinCor Pharma Funding FAQs
What does CinCor Pharma do?
CinCor is a clinical-stage biopharmaceutical company with a mission to advance promising clinical candidates toward marketing approval. CinCor’s focus is on cardiovascular, metabolic and kidney diseases. CinCor’s lead program is CIN-107, a novel aldosterone synthase inhibitor.
How much funding has CinCor Pharma raised?
CinCor Pharma has raised $225M across 1 round on record. The most recent is a Post-IPO Equity of $225M announced in Aug 2022.
When did CinCor Pharma last raise funding?
CinCor Pharma's most recent funding round on record is a Post-IPO Equity of $225M, announced in Aug 2022.
Who is the CEO of CinCor Pharma?
Marc De Garidel is listed as CEO at CinCor Pharma.
Where is CinCor Pharma headquartered?
CinCor Pharma is based in Cincinnati, Ohio, United States.
How many employees does CinCor Pharma have?
CinCor Pharma is in the 11-50 employee band.
How does CinCor Pharma's funding compare to other Biotechnology startups?
CinCor Pharma's latest round of $225M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's CinCor Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for CinCor Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.